https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-08-01 / Expert Rev Vaccines 2007 Aug;6(4):617-33
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-08-01 / Expert Rev Vaccines 2007 Aug;6(4):617-332007-08-01 00:00:002007-08-01 00:00:00Dendritic cell vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-04-20 / Clin. Immunol. 2007 Jun;123(3):298-310
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-04-20 / Clin. Immunol. 2007 Jun;123(3):298-3102007-04-20 00:00:002019-02-15 09:16:58Radiation-induced apoptosis along with local and systemic cytokine elaboration is associated with DC plus radiotherapy-mediated renal cell tumor regression
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-04-19 / Cancer Immunol. Immunother. 2007 Nov;56(11):1817-29
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-04-19 / Cancer Immunol. Immunother. 2007 Nov;56(11):1817-292007-04-19 00:00:002019-02-15 08:48:10DC immunotherapy is highly effective for the inhibition of tumor metastasis or recurrence, although it is not efficient for the eradication of established solid tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-02-01 / Expert Opin Biol Ther 2007 Feb;7(2):221-32
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-02-01 / Expert Opin Biol Ther 2007 Feb;7(2):221-322007-02-01 00:00:002019-02-15 09:17:00Dendritic cell vaccine strategies for renal cell carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-01 / Adv. Exp. Med. Biol. 2007;601:387-93
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-01 / Adv. Exp. Med. Biol. 2007;601:387-932007-01-01 00:00:002019-02-15 09:16:56Cell technologies in immunotherapy of cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-01 / J. Immunother. 2007 Jan;30(1):116-22
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-01 / J. Immunother. 2007 Jan;30(1):116-222007-01-01 00:00:002019-02-15 09:17:01Preliminary analysis of patients with progressive renal cell carcinoma vaccinated with CA9-peptide-pulsed mature dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-11-15 / Cancer Immunol. Immunother. 2007 Jun;56(6):897-903
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-11-15 / Cancer Immunol. Immunother. 2007 Jun;56(6):897-9032006-11-15 00:00:002019-02-15 09:16:59Antigen-independent immune responses after dendritic cell vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-11-01 / In Vivo 2006 Nov-Dec;20(6A):689-95
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-11-01 / In Vivo 2006 Nov-Dec;20(6A):689-952006-11-01 00:00:002006-11-01 00:00:00Hyperthermia and immunity. A brief overview
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-06-01 / Cancer Res. 2006 Jun;66(11):5910-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-06-01 / Cancer Res. 2006 Jun;66(11):5910-82006-06-01 00:00:002019-02-15 09:17:03Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-05-04 / Sao Paulo Med J 2006 May;124(3):161-2
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-05-04 / Sao Paulo Med J 2006 May;124(3):161-22006-05-04 00:00:002024-12-03 08:04:16Pure sarcomatous recurrence of clear cell renal carcinoma following radical nephrectomy and dendritic cell vaccination
